Emerging in the arena of obesity management, retatrutide presents a different strategy. Unlike many existing medications, retatrutide functions as a twin agonist, at once targeting both GLP-like peptide-1 (GLP-1) and https://lilliixzw684584.thenerdsblog.com/44656726/this-new-retatrutide-this-glp-gip-binding-site-agonist